HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Congenital adrenal hyperplasia caused by 11-beta-hydroxylase deficiency].

Abstract
The author describes the clinical presentation, diagnostic and therapeutic management of 11-beta-hydroxylase deficiency, a form of congenital adrenal hyperplasia second to 21-hydroxylase deficiency. The importance of an early diagnosis is emphasized in avoiding irreversible somatic disorders, mental aberrations and organic lesions. The paper discusses factors that may delay diagnosis and points to the key importance of a physical examination combined with routine assessment of growth and sexual maturation from the neonatal period on in diagnostic management of not only 11-beta-hydroxylase deficiency, but also other causes of sexual ambiguity and precocious puberty.
AuthorsJ Starzyk
JournalEndokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych (Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw) Vol. 6 Issue 2 Pg. 121-7 ( 2000) ISSN: 1234-625X [Print] Poland
Vernacular TitleWrodzony przerost nadnerczy spowodowany niedoborem 11-beta-hydroksylazy.
PMID12818073 (Publication Type: English Abstract, Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: